Azitra Inc

Azitra Inc company information, Employees & Contact Information

Explore related pages

Related company profiles:

Azitra, Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. Azitra’s lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. ATR-04, Azitra's additional clinical program, utilizes another engineered strain of S. epidermidis for the treatment of EGFR inhibitor ("EGFRi") associated skin toxicity. The ATR-12 and ATR-04 programs were developed from Azitra's proprietary platform of engineered proteins and topical live biotherapeutic products that includes a microbial library comprised of approximately 1,500 bacterial strains. The Company was founded in 2014 by scientists from Yale University and works with world-leading scientists in dermatology, microbiology, and genetic engineering to advance its programs in atopic dermatitis and targeted orphan indications. For more information visit www.azitrainc.com.

Company Details

Employees
12
Founded
-
Address
21 Business Park Dr, Branford,connecticut 06405,united States
Phone
(203)599-0700
Email
in****@****inc.com
Industry
Biotechnology
HQ
Branford, Connecticut
Looking for a particular Azitra Inc employee's phone or email?

Azitra Inc Questions

News

Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit - Sahm

Azitra to Participate in Dermatologic Rare Disease Panel at Maxim Growth Summit Sahm

Azitra, Inc. Announces Reverse Stock Split - Morningstar

Azitra, Inc. Announces Reverse Stock Split Morningstar

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Yahoo Finance

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris - The AI Journal

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris The AI Journal

Azitra Receives Notice of Non-Compliance from NYSE American - StreetInsider

Azitra Receives Notice of Non-Compliance from NYSE American StreetInsider

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock - Yahoo Finance

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock Yahoo Finance

Top Azitra Inc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant